You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 79 No. 6, June 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Treatment of Alopecia Universalis with Methyl Prednisolone (Medrol)

Associated with Vitiligo Involving Arms, Forearms, Neck, and Thigh

IRWIN I. LUBOWE, M.D.

AMA Arch Derm. 1959;79(6):665-668.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

I have described previously in three articles1,2,5 the treatment of alopecia areata, universalis, and totalis by the cautious use of cortisone, hydrocortisone, and their analogues, prednisone and prednisolone. In the later report,2 I tabulated the result of treatment of 68 patients with alopecia areata, totalis, and universalis with methyl prednisolone (Medrol*). In a recent communication4 in the ARCHIVES I have also suggested the possible pathogenetic relationship between hypopigmentation and melanocyte formation associated with alopecia areata and totalis. The duration of the alopecia ranged from 3 months to 25 years. I concluded that 62% of the male patients had complete regrowth and 38% had partial regrowth; also 58% of the female patients had complete regrowth, and 42% had partial regrowth.

In conjunction with the intake of methyl prednisolone orally, regular periodic intra-muscular injections of corticotropin (ACTH) are given weekly at . . . [Full Text PDF of this Article]


Author Affiliations

New York


Footnotes

Submitted for publication Oct. 17, 1958.

Clinical Assistant Professor of Dermatology, New York Medical College, and Associate Visiting Dermatologist, Metropolitan Medical Center.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.